ScholarIQanswers from OpenAlex & ORCID
Janet Dancey
ResearcherPublications, citations & collaboration network
Janet Dancey is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Janet Dancey have?
ScholarIQindexed works
Janet Dancey has 311 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Janet Dancey have?
ScholarIQcitation count
Janet Dancey has 55,897 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Janet Dancey?
ScholarIQh-index
Janet Dancey has an h-index of 81 in OpenAlex.
What is the i10-index of Janet Dancey?
ScholarIQi10-index
Janet Dancey has an i10-index of 173 in OpenAlex.
What is the OpenAlex record for Janet Dancey?
ScholarIQopenalex
The OpenAlex for Janet Dancey is on the source record.
What are the most-cited papers on Janet Dancey?
ScholarIQmost cited works
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
Frances A. Shepherd, Janet Dancey, Rodryg Ramlau, K. Mattson, Richard J. Gralla, Mark Allen O’Rourke, Nathan Levitan, Laurent Gressot, Mark Vincent, Ronald L. Burkes, Susan Coughlin, Yong Kim, J. Bérille
Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
Amit M. Oza, Laurie Elit, Ming‐Sound Tsao, Suzanne Kamel‐Reid, Jim Biagi, Diane Provencher, Walter H. Gotlieb, Paul Hoskins, Prafull Ghatage, Katia Tonkin, Helen Mackay, J. Mazurka, Joana Sederias, Percy Ivy, Janet Dancey, Elizabeth A. Eisenhauer
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas
Ignacio Durán, Jeremy Kortmansky, Deepti Singh, Hal W. Hirte, Walter Kocha, Glenwood D. Goss, Lyly Le, Amit M. Oza, Trudey Nicklee, Jcm Ho, Diana C. Birle, Gregory R. Pond, D Arboine, Janet Dancey, Sarit Aviel‐Ronen, M-S Tsao, David W. Hedley, Lillian L. Siu
Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands
Mark Agulnik, Ezra E.W. Cohen, Roger B. Cohen, Eric X. Chen, Everett E. Vokes, Sebastién J. Hotte, Eric Winquist, Scott A. Laurie, D. Neil Hayes, Janet Dancey, Shirley Brown, Gregory R. Pond, Ian Lorimer, Manijeh Daneshmand, Jcm Ho, Ming‐Sound Tsao, Lillian L. Siu